Gene Sequencing tests in Dubai & UAE

Compare available Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

143

Listed price range

2,600.00–3,200.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Gene Sequencing test prices

Showing 121–135 of 143 matching tests.

Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4046 SMAD6 Gene Aortic Valve Disease Type 2 Test This genetic test evaluates the SMAD6 gene for variants associated with aortic valve disease type 2 and thoracic aortic aneurysms.	Peripheral Whole Blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SMAD6 gene", "Full gene coverage including exons, splice sites, and indels"] Parameters [] Preparation [] Indications ["Individuals with a family history of bicuspid aortic valve", "Individuals with a family history of early aortic dissection", "Individuals with a family history of related aortopathies"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: I35.9 Clinical summary This genetic test evaluates the SMAD6 gene for variants associated with aortic valve disease type 2 and thoracic aortic aneurysms.
TEST-4790 SMARCA1 Gene X‑Linked Mental Retardation Genetic Test This test identifies pathogenic variants within the SMARCA1 gene associated with X-linked intellectual disability.	Peripheral whole blood, FTA card, or extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in SMARCA1 gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation [] Indications ["Confirmatory diagnosis of X-linked intellectual disability", "Carrier testing", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 94727-5 ICD-10: Q99.8 Clinical summary This test identifies pathogenic variants within the SMARCA1 gene associated with X-linked intellectual disability.
TEST-3476 SRY Gene 46,XX Sex Reversal Type 1 (NGS) Test This diagnostic test evaluates for pathogenic variants within the SRY gene, which are the primary cause of 46,XX sex reversal type 1.	Peripheral Whole Blood (EDTA) or Buccal Swab	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in SRY gene (SNVs, Indels, CNVs)", "SRY gene copy number variations"] Parameters [] Preparation [] Indications ["Diagnosis of 46,XX testicular disorder of sex development (DSD)", "Confirmation of 46,XX sex reversal type 1"] Measurement technique Confirm with laboratory Codes LOINC: 21642-1 ICD-10: Q98.3 Clinical summary This diagnostic test evaluates for pathogenic variants within the SRY gene, which are the primary cause of 46,XX sex reversal type 1.
TEST-6259 SSR4 Gene X-Linked Congenital Disorder of Glycosylation (CDG) Genetic Test This genetic test analyzes the SSR4 gene to detect mutations causing X-linked congenital disorder of glycosylation (CDG type Iy). It identifies single nucleotide variants, insertio...	Peripheral Whole Blood (3 mL EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SSR4 gene sequence", "Copy number variations (CNVs) in SSR4 gene"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Suspected X-linked congenital disorder of glycosylation (CDG type Iy)", "Individuals with clinical features suggestive of CDG Iy", "Family planning for families with a history of CDG Iy"] Measurement technique Confirm with laboratory Codes LOINC: 91247-1 ICD-10: E77.8 Clinical summary This genetic test analyzes the SSR4 gene to detect mutations causing X-linked congenital disorder of glycosylation (CDG type Iy). It identifies single nucleotide variants, insertions, deletions, and copy number changes.
TEST-3824 STAT5B Gene Sequencing (Growth Hormone Insensitivity with Immunodeficiency) Test This test identifies pathogenic variants within the STAT5B gene, which are associated with growth hormone insensitivity and severe immunodeficiency.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the STAT5B gene", "Single-nucleotide variants", "Small insertions/deletions", "Splice-site alterations"] Parameters [] Preparation ["No fasting required", "No medication changes required", "Inform phlebotomist of recent blood transfusions or stem cell therapy"] Indications ["Suspected growth hormone insensitivity", "Combined immunodeficiency", "Recurrent or severe infections", "Failure to thrive"] Measurement technique Confirm with laboratory Codes LOINC: 55231-4 ICD-10: E34.3, D84.9 Clinical summary This test identifies pathogenic variants within the STAT5B gene, which are associated with growth hormone insensitivity and severe immunodeficiency.
TEST-2555 STIL Gene Autosomal Recessive Primary Microcephaly Type 7 (MCPH7) Genetic Test This test identifies pathogenic variants in the STIL gene associated with autosomal recessive primary microcephaly type 7 (MCPH7).	Whole Blood (EDTA) or FTA Card (Dried Blood Spot)	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["STIL gene coding exons", "STIL gene splice junctions", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["Pre-test genetic counselling session is mandatory"] Indications ["Infants with congenital microcephaly", "Children with unexplained intellectual disability", "Siblings of a confirmed MCPH7 case"] Measurement technique Confirm with laboratory Codes LOINC: 79714-0 ICD-10: Q02, Z13.79, Z82.71 Clinical summary This test identifies pathogenic variants in the STIL gene associated with autosomal recessive primary microcephaly type 7 (MCPH7).
TEST-3465 STRC Gene Deafness and Male Infertility Genetic Test This genetic test evaluates the STRC gene for pathogenic variants associated with autosomal recessive non-syndromic hearing loss and male infertility.	Peripheral Whole Blood, Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the STRC gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist about bleeding disorders or anticoagulant use"] Indications ["Autosomal recessive non-syndromic hearing loss", "Male infertility", "Family history of hearing loss or infertility"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: H90.5, N46.9 Clinical summary This genetic test evaluates the STRC gene for pathogenic variants associated with autosomal recessive non-syndromic hearing loss and male infertility.
TEST-5808 SUMF1 Gene Sulfatase Deficiency Genetic Test This genetic test evaluates the SUMF1 gene for pathogenic variants associated with Multiple Sulfatase Deficiency (MSD). It identifies mutations, deletions, and duplications within...	Peripheral whole blood (5 ml in EDTA tube) or Buccal Swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SUMF1 gene sequence", "Copy number variations (CNVs) in SUMF1 gene"] Parameters [] Preparation ["No fasting required", "Simple blood draw or buccal swab sufficient"] Indications ["Suspected Multiple Sulfatase Deficiency (MSD)", "Carrier screening in families with MSD", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94222-8 ICD-10: E75.26 Clinical summary This genetic test evaluates the SUMF1 gene for pathogenic variants associated with Multiple Sulfatase Deficiency (MSD). It identifies mutations, deletions, and duplications within the gene.
TEST-5636 TANC1 Gene Psychomotor Retardation Genetic Test This genetic test identifies pathogenic variants in the TANC1 gene, which are associated with autosomal dominant psychomotor retardation.	Whole blood, extracted DNA, or dried blood spot (FTA card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TANC1 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of recent blood transfusions"] Indications ["Suspected TANC1-related disorder", "Autosomal dominant psychomotor retardation"] Measurement technique Confirm with laboratory Codes LOINC: 10213-6 ICD-10: Z13.71 Clinical summary This genetic test identifies pathogenic variants in the TANC1 gene, which are associated with autosomal dominant psychomotor retardation.
TEST-4837 TGFBR2 Gene Loeys-Dietz Syndrome Type 1B Genetic Test This test identifies pathogenic variants in the TGFBR2 gene associated with Loeys-Dietz syndrome type 1B.	Peripheral Whole Blood (Venous or FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TGFBR2 gene", "TGF-β signalling pathway disruption"] Parameters [] Preparation [] Indications ["Clinically suspected Loeys-Dietz syndrome type 1B", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 82771-1 ICD-10: Q87.89 Clinical summary This test identifies pathogenic variants in the TGFBR2 gene associated with Loeys-Dietz syndrome type 1B.
TEST-4567 TIMM8A Gene Jensen Syndrome Genetic Test This genetic test identifies disease-causing mutations in the TIMM8A gene associated with Jensen syndrome.	Peripheral Whole Blood (or DNA‑stabilised FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TIMM8A gene", "Coding exons", "Flanking intronic regions", "Deep intronic hotspots"] Parameters [] Preparation ["Genetic counselling session required prior to sample collection", "No specific fasting required for blood sample"] Indications ["Clinically suspected cases of Jensen syndrome", "Family history of Jensen syndrome", "Confirmation of clinical diagnosis", "Genetic counselling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 81247-1 ICD-10: G31.8, H90.5, Z84.3 Clinical summary This genetic test identifies disease-causing mutations in the TIMM8A gene associated with Jensen syndrome.
TEST-5251 TMCO1 Gene Sequencing (NGS) Test This test identifies pathogenic variants in the TMCO1 gene, which are associated with a specific syndrome characterized by craniofacial dysmorphism, skeletal anomalies, and intelle...	Whole Blood (EDTA) or Saliva (Oragene®)	21–28 days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TMCO1 gene", "Single-nucleotide variants", "Insertions/deletions", "Copy-number aberrations"] Parameters [] Preparation ["No specific patient preparation required"] Indications ["Suspected TMCO1-related disorder", "Differential diagnosis of craniofacial-skeletal-intellectual disability syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 94222-5 ICD-10: Q87.8, Q87.0, Q75.8 Clinical summary This test identifies pathogenic variants in the TMCO1 gene, which are associated with a specific syndrome characterized by craniofacial dysmorphism, skeletal anomalies, and intellectual disability.
TEST-6268 TMEM165 Gene CDG Type 2K Genetic Test This test identifies pathogenic variants in the TMEM165 gene, confirming a diagnosis of Congenital Disorder of Glycosylation Type 2K (CDG-IIK).	Peripheral Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants (SNVs, indels, CNVs) in the TMEM165 gene", "Defective protein glycosylation pathway"] Parameters [] Preparation ["No fasting required", "Maintain good hydration", "Mandatory pre-test genetic counseling session required"] Indications ["Clinical suspicion of Congenital Disorder of Glycosylation Type 2K (CDG-IIK)", "Patients with symptoms suggestive of a rare metabolic disorder involving glycosylation"] Measurement technique Confirm with laboratory Codes LOINC: 81799-6 ICD-10: E77.8 Clinical summary This test identifies pathogenic variants in the TMEM165 gene, confirming a diagnosis of Congenital Disorder of Glycosylation Type 2K (CDG-IIK).
TEST-4687 TNFRSF11A Gene: Familial Expansile Osteolysis Test This test identifies mutations in the TNFRSF11A gene associated with familial expansile osteolysis.	Whole Blood (Peripheral)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TNFRSF11A gene mutations", "Single-nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation [] Indications ["Suspected familial expansile osteolysis (FEO)", "Associated bone disorders", "Overlapping dermatologic and immunologic symptoms", "Family screening for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 78337-6 ICD-10: M89.58, Q78.8, Z15.89 Clinical summary This test identifies mutations in the TNFRSF11A gene associated with familial expansile osteolysis.
TEST-5372 TNNT3 Gene (Arthrogryposis, Distal, Type 2B) Genetic Test This genetic test evaluates the TNNT3 gene for pathogenic variants associated with distal arthrogryposis type 2B.	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNNT3 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any active illness"] Indications ["Diagnosis of distal arthrogryposis type 2B", "Familial risk assessment", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 81316-3 ICD-10: Q74.3 Clinical summary This genetic test evaluates the TNNT3 gene for pathogenic variants associated with distal arthrogryposis type 2B.

Category overview

Gene Sequencing: overview

Achieving a definitive diagnosis for a complex or rare genetic disorder often requires reading the entire genetic code of specific genes to find elusive, hidden errors. As a cornerstone of our advanced Genetics services, Gene Sequencing expansively scans the targeted regions of your genome to uncover rare or novel mutations that standard tests miss. Utilizing state-of-the-art sequencing technology, this comprehensive molecular profiling delivers the critical data necessary to safely guide your healthcare provider in tailoring highly personalized medical management and targeted therapeutic interventions. Trusted for molecular excellence among premier diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and remarkably fast reporting. Find the clear, definitive answers you need—schedule your gene sequencing testing in UAE, coordinate a seamless clinical sample transfer, or consult our expert medical genetics professionals today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.